Monte Rosa Therapeutics, Inc (GLUE) insider trading
Every open-market stock purchase and sale by Monte Rosa Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Matthew Bowen (Insider) sold $137 in the last 90 days.
- Last insider buy: Chandra P. Leo (Insider), $58.4K, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $4.1M (31 sales). Last close $11.11 on Oct 22, 2026.
Recent GLUE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 5, 2026 | Matthew Bowen (Insider) | Sold | $137 |
| Jul 16, 2026 | Markus Warmuth (CEO) | Sold | $220K |
| Jul 15, 2026 | Jennifer Champoux (COO) | Sold | $102K |
| Jul 15, 2026 | Jennifer Champoux (COO) | Bought (not open market) | $17.3K |
| Jul 15, 2026 | Jennifer Champoux (COO) | Bought (not open market) | — |
| Jul 6, 2026 | Sharon Townson (C-suite exec) | Sold | $130K |
| Jul 6, 2026 | Sharon Townson (C-suite exec) | Bought (not open market) | $36.8K |
| Jul 6, 2026 | Sharon Townson (C-suite exec) | Sold | $9.7K |
| Jul 6, 2026 | Sharon Townson (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Ali Behbahani (Insider) | Sold (not open market) | — |
| Jul 1, 2026 | Ali Behbahani (Insider) | Bought (not open market) | — |
| Jul 1, 2026 | Ali Behbahani (Insider) | Sold (not open market) | — |
| Jun 30, 2026 | Filip Janku (C-suite exec) | Sold | $132K |
| Jun 30, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | $72.5K |
| Jun 30, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Anthony M. Manning (Insider) | Sold | $231K |
| Jun 29, 2026 | Filip Janku (C-suite exec) | Sold | $138K |
| Jun 29, 2026 | Anthony M. Manning (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 24, 2026 | Filip Janku (C-suite exec) | Sold | $643K |
| Jun 24, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 23, 2026 | Filip Janku (C-suite exec) | Sold | $240K |
| Jun 23, 2026 | Sharon Townson (C-suite exec) | Sold | $60K |
| Jun 23, 2026 | Jennifer Champoux (COO) | Sold | $43.5K |
| Jun 23, 2026 | Jennifer Champoux (COO) | Bought (not open market) | — |
Who's trading GLUE
- Matthew Bowen, Insider: sold $137 (1 sale), last Oct 5, 2026
- Markus Warmuth, CEO: sold $951K (10 sales), last Jul 16, 2026
- Jennifer Champoux, COO: sold $311K (6 sales), last Jul 15, 2026
- Sharon Townson, C-suite exec: sold $424K (6 sales), last Jul 6, 2026
- Ali Behbahani, Insider: other filings, last Jul 1, 2026
- Filip Janku, C-suite exec: sold $1.4M (6 sales), last Jun 30, 2026
- Anthony M. Manning, Insider: sold $411K (2 sales), last Jun 29, 2026
- Kimberly Blackwell, Insider: other filings, last Jun 11, 2026
- Andrew N Schiff, Insider: other filings, last Jun 11, 2026
- Christine Siu, Insider: other filings, last Jun 11, 2026
- Jan Skvarka, Insider: other filings, last Jun 11, 2026
- Eric A Hughes, Insider: other filings, last Jun 11, 2026
- Philip Nickson, Officer: sold $151K (2 sales), last Apr 9, 2026
- Edmund Dunn, Insider: sold $483K (4 sales), last Mar 4, 2026
Get free alerts when an insider at Monte Rosa Therapeutics, Inc files a new trade →